After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and new therapeutic targets fueling cautious hope.

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he battles a rare variant.

Health Life Nation Nation & World AI tool identifies 9 dementia types, including Alzheimer’s, with one scan July 2, 2025 at 6:19 am By Mayo Clinic News Network ...

RBC Capital maintained its Outperform rating on Xenon Pharmaceuticals Inc. (NASDAQ:XENE) and increased its price target from $55 to $57 on June 13.

June marked Alzheimer’s and Brain Awareness Month—a timely opportunity to bring attention to a disease that affects millions.

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early stages of the mind-robbing disease in a mid-stage study, sending its shares ...

Four climbers went up and down Everest in under a week with the help of xenon gas—a record-breaking ascent that has ignited controversy in the mountaineering world.

Currently, there is a distinctive lack of effective clinical strategies to obviate this problem. Xenon, a noble gas with anesthetic properties, exhibits neuroprotective effects.

--Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced ...

The challenges in the current treatment landscape for Alzheimer’s disease (AD) underscore the urgent need for novel therapeutic strategies targeting multiple pathological pathways. Recent studies have ...

A small crew out of the UK summited Everest in days with the help of xenon gas. Here's what xenon gas is, why it's used for climbing, and the risks of using it.